A study to test the safety of a new medicine in children with DMD
Research type
Research Study
Full title
SMT C1100 - A Phase 1, Open-label, Single and Multiple Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Paediatric Patients with Duchenne Muscular Dystrophy
IRAS ID
136017
Contact name
Francesco Muntoni
Contact email
Sponsor organisation
Summit Corporation plc
Eudract number
2013-002115-99
REC name
London - West London & GTAC Research Ethics Committee
REC reference
13/LO/1258
Date of REC Opinion
31 Oct 2013
REC opinion
Further Information Favourable Opinion